Painful versus Insensate Diabetic Neuropathy
疼痛性糖尿病神经病与无知觉性糖尿病神经病
基本信息
- 批准号:8123110
- 负责人:
- 金额:$ 32.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-01-01 至 2014-08-31
- 项目状态:已结题
- 来源:
- 关键词:A/J MouseAccountingAddressAffectAntioxidantsAxonBehavioralDevelopmentDiabetes MellitusDiabetic NeuropathiesDiabetic mouseEpidermisEtiologyFiberGDNF geneGenesGeneticGoalsGreen Fluorescent ProteinsHumanHyperinsulinismImageryInsulinInsulin ReceptorInsulin ResistanceLeadMeasuresMechanicsMediator of activation proteinModelingModificationMusNeuronsNeuropathyNeurotrophin 3NociceptionOutcomeOxidative StressPainPathogenesisPatientsPeripheralPeroxonitritePlayRelative (related person)RoleSensorySeveritiesStreptozocinSymptomsTestingTransgenic MiceVariantaxonal degenerationcatalystdb/db mousediabetic patientexperiencehuman IRS2 proteinin vivomouse modelneurotrophic factornew therapeutic targetpreventpromoterpublic health relevancereceptor expressionrelating to nervous systemresearch studyresponsetooltype I and type II diabetes
项目摘要
DESCRIPTION (provided by applicant): The mechanisms that lead to painful or insensate symptoms in diabetic neuropathy (DN) are poorly understood. Many variables likely play a role in the development of these diverse symptoms, including reduced neurotrophic supply, abnormal insulin support, and oxidative stress. These symptoms may also underlie peripheral axon damage amongst select sensory neuronal subpopulations. Our long-term goal is to understand the etiology of painful and/or insensate complications of DN in relation to insulin support, oxidative stress, and peripheral axon degeneration. The central hypothesis of this proposal is that unique genetic differences underlie the differential progression and severity of diabetic neuropathy. Exploring these genetic differences will help identify mechanisms involved in the pathogenesis of diabetic neuropathy. Aim 1 will characterize the progression of painful and insensate neuropathy in type 1 (STZ- A/J vs. STZ-C57Bl/6) and type 2 (ob/ob vs. db/db) mouse models of diabetes and test whether neurotrophins can alleviate the diabetes-induced abnormalities in mechanical sensitivity. Aim 2 will test whether insulin support plays a critical role in the progression of painful or insensate neuropathy amongst these variant mouse models of diabetes. Aim 3 will examine the role of oxidative stress in the development of painful or insensate neuropathy in these diabetic mice. Aim 4 will determine whether differential damage to epidermal axons is important factor in developing painful or insensate diabetic neuropathy. Collectively, these studies will identify three possible mechanisms responsible for the variable progression of symptoms experienced within human patients and identify new therapeutic targets aimed at the severity of symptoms amongst diabetic patients.
PUBLIC HEALTH RELEVANCE:
This proposal will elucidate mechanisms related to the development of painful versus nonpainful symptoms in mouse models of diabetic neuropathy. The role of neurotrophins, insulin support, oxidative stress, and axonal degeneration will be investigated to identify mechanisms that lead to the neural complications associated with diabetes.
描述(由申请人提供):导致糖尿病性神经病变(DN)疼痛或麻木症状的机制尚不清楚。许多变量可能在这些不同症状的发展中起作用,包括神经营养供应减少,胰岛素支持异常和氧化应激。这些症状也可能是外周轴突损伤的基础在选择的感觉神经元亚群。我们的长期目标是了解与胰岛素支持、氧化应激和外周轴突变性有关的DN疼痛和/或不敏感并发症的病因。该建议的中心假设是独特的遗传差异是糖尿病神经病变不同进展和严重程度的基础。探索这些遗传差异将有助于确定糖尿病神经病变发病机制。目的1将描述1型(STZ- A/J vs. STZ- c57bl /6)和2型(ob/ob vs. db/db)糖尿病小鼠模型中疼痛和麻木神经病变的进展,并测试神经营养因子是否可以减轻糖尿病诱导的机械敏感性异常。目的2将测试胰岛素支持是否在这些糖尿病小鼠模型中疼痛或麻木神经病变的进展中起关键作用。目的3将检查氧化应激在这些糖尿病小鼠疼痛或麻木神经病变发展中的作用。目的4将确定表皮轴突的不同损伤是否是发生疼痛性或无感觉性糖尿病神经病变的重要因素。总的来说,这些研究将确定三种可能的机制,负责人类患者经历的症状的可变进展,并确定针对糖尿病患者症状严重程度的新治疗靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Douglas E Wright其他文献
Douglas E Wright的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Douglas E Wright', 18)}}的其他基金
Kansas IDeA Network of Biomedical Research Excellence
堪萨斯 IDeA 生物医学研究卓越网络
- 批准号:
7900634 - 财政年份:2009
- 资助金额:
$ 32.16万 - 项目类别:
Kansas IDeA Network of Biomedical Research Excellence
堪萨斯 IDeA 生物医学研究卓越网络
- 批准号:
7900633 - 财政年份:2009
- 资助金额:
$ 32.16万 - 项目类别:
Kansas IDeA Network of Biomedical Research Excellence
堪萨斯 IDeA 生物医学研究卓越网络
- 批准号:
7893336 - 财政年份:2009
- 资助金额:
$ 32.16万 - 项目类别:
Painful versus Insensate Diabetic Neuropathy
疼痛性糖尿病神经病与无知觉性糖尿病神经病
- 批准号:
8322109 - 财政年份:2003
- 资助金额:
$ 32.16万 - 项目类别:
Painful versus Insensate Diabetic Neuropathy
疼痛性糖尿病神经病与无知觉性糖尿病神经病
- 批准号:
7924551 - 财政年份:2003
- 资助金额:
$ 32.16万 - 项目类别:
Painful versus insensate diabetic neuropathy
疼痛性糖尿病神经病变与无知觉性糖尿病神经病变
- 批准号:
8987979 - 财政年份:2003
- 资助金额:
$ 32.16万 - 项目类别:
相似海外基金
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 32.16万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
- 批准号:
10100360 - 财政年份:2024
- 资助金额:
$ 32.16万 - 项目类别:
Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
- 批准号:
24K04974 - 财政年份:2024
- 资助金额:
$ 32.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
- 批准号:
23K01686 - 财政年份:2023
- 资助金额:
$ 32.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
- 批准号:
23K01692 - 财政年份:2023
- 资助金额:
$ 32.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
- 批准号:
23K01695 - 财政年份:2023
- 资助金额:
$ 32.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
- 批准号:
23K01713 - 财政年份:2023
- 资助金额:
$ 32.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
- 批准号:
2312319 - 财政年份:2023
- 资助金额:
$ 32.16万 - 项目类别:
Standard Grant
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
- 批准号:
23K01715 - 财政年份:2023
- 资助金额:
$ 32.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
- 批准号:
10585388 - 财政年份:2023
- 资助金额:
$ 32.16万 - 项目类别: